Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Shimada, Hideaki"" wg kryterium: Autor


Tytuł:
The Outcome of Conversion to Hand-Assisted Laparoscopic Surgery in Laparoscopic Liver Resection.
Autorzy:
Nakada S; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Otsuka Y; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Ishii J; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Maeda T; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Kimura K; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Matsumoto Y; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Ito Y; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Shimada H; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Funahashi K; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Ohtsuka M; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Kaneko H; Division of General and Gastroenterological Surgery, Department of Surgery, Toho University Faculty of Medicine, 6-11-1, Omorinishi, Otaku, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 Jul 21; Vol. 12 (14). Date of Electronic Publication: 2023 Jul 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer.
Autorzy:
Yoshida K; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Hiwasa T; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan.; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Ito M; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan.
Ushigome M; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Takizawa H; Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chiba 260-0025, Japan.
Li SY; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Zhang BS; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Iwadate Y; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8670, Japan.
Funahashi K; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Shimada H; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2023 Feb 10; Vol. 25 (3), pp. 127. Date of Electronic Publication: 2023 Feb 10 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma.
Autorzy:
Hirokawa S; Department of Otorhinolaryngology-Head and Neck Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Araki K; Department of Otorhinolaryngology-Head and Neck Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Yamashita T; Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Uno K; Department of Otorhinolaryngology-Head and Neck Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Tomifuji M; Department of Otorhinolaryngology-Head and Neck Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Shimada H; Department of Surgery, School of Medicine, Toho University Omori Medical Center, Tokyo, Japan.
Shiotani A; Department of Otorhinolaryngology-Head and Neck Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
Pokaż więcej
Źródło:
Acta oto-laryngologica [Acta Otolaryngol] 2023 Jan; Vol. 143 (1), pp. 85-90. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article
MeSH Terms:
Pharyngeal Neoplasms*/diagnosis
Squamous Cell Carcinoma of Head and Neck*/diagnosis
Humans ; Antibodies ; Biomarkers, Tumor ; Tumor Suppressor Protein p53
Czasopismo naukowe
Tytuł:
Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal Society.
Autorzy:
Suzuki T; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Yajima S; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Okamura A; Department of Gastroenterological Surgery, Gastroenterology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
Yoshida N; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8555, Japan.
Taniyama Y; Department of Digestive Surgery, Tohoku University Graduate School of Medicine, Miyagi 980-8574, Japan.
Murakami K; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba 263-8522, Japan.
Ohkura Y; Department of Gastroenterological Surgery, Toranomon Hospital and Okinaka Memorial Institute for Medical Research, Tokyo 105-8470, Japan.
Nakajima Y; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Yagi K; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Fukuda T; Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, Saitama 362-0806, Japan.
Ogawa R; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Aichi 467-8601, Japan.
Hoshino I; Division of Gastroenterological Surgery, Chiba Cancer Center, Chiba 260-8717, Japan.
Kunisaki C; Department of Surgery, Gastroenterological Center, Yokohama City University, Kanagawa 236-0004, Japan.
Narumiya K; Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Tsubosa Y; Division of Esophageal Surgery, Shizuoka Cancer Center, Shizuoka 411-8777, Japan.
Yamada K; Department of Surgery, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
Shimada H; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Pokaż więcej
Corporate Authors:
Japan Esophageal Society Promotion Research: p53 Antibody Multicenter Research Group
Źródło:
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus [Dis Esophagus] 2022 Dec 14; Vol. 35 (12).
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Esophageal Squamous Cell Carcinoma*/surgery
Esophageal Neoplasms*/pathology
Carcinoma, Squamous Cell*/pathology
Serpins*
Humans ; Carcinoembryonic Antigen ; Prognosis ; Retrospective Studies ; Japan/epidemiology ; Antigens, Neoplasm ; Biomarkers, Tumor
Czasopismo naukowe
Tytuł:
Taxane-based versus platinum-based chemotherapy in early recurrent gastric cancer after radical surgery with S-1 adjuvant chemotherapy: A multi-institutional retrospective analysis.
Autorzy:
Nagaoka S; Department of Gastroesophageal Surgery, Japanese Red Cross Medical Center, Tokyo, Japan.
Yamashita H; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Seto Y; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Fujisaki M; Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
Mitsumori N; Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.
Oshima Y; Department of Surgery (Omori), Division of General and Gastroenterological Surgery, Toho University, Tokyo, Japan.
Yajima S; Department of Surgery (Omori), Division of General and Gastroenterological Surgery, Toho University, Tokyo, Japan.
Kikuchi Y; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Faculty of Medicine, Toho University, Tokyo, Japan.
Otsuka K; Department of Surgery, Division of Gastroenterological and General Surgery, School of Medicine, Showa University, Tokyo, Japan.
Murakami M; Department of Surgery, Division of Gastroenterological and General Surgery, School of Medicine, Showa University, Tokyo, Japan.
Fujita S; Department of Surgery, Toho University Ohashi Medical Center, Tokyo, Japan.
Futawatari N; Department of Surgery, Toho University Ohashi Medical Center, Tokyo, Japan.
Shimada H; Department of Surgery (Omori), Division of General and Gastroenterological Surgery, Toho University, Tokyo, Japan.; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Dec; Vol. 18 (6), pp. 540-545. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/surgery
Humans ; Retrospective Studies ; Platinum/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Taxoids/therapeutic use ; Chemotherapy, Adjuvant
Czasopismo naukowe
Tytuł:
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study.
Autorzy:
Okada R; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Otsuka Y; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Yokosuka O; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8677, Japan.
Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8677, Japan.
Imazaki F; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba-shi, Chiba 260-8677, Japan.
Hoshino I; Department of Surgery, Chiba Cancer Center, Chiba-shi, Chiba 260-8717, Japan.
Sugiura N; Department of Gastroenterology, Japan Community Health Care Organization Chiba Hospital, Chiba-shi, Chiba 260-8710, Japan.
Mizumoto H; Department of Gastroenterology, Funabashi Municipal Medical Center, Funabashi, Chiba 273-8588, Japan.
Azemoto R; Department of Gastroenterology, Kimitsu Chuo Hospital, Kimitsu, Chiba 292-8535, Japan.
Kato K; Department of Gastroenterology, Japan Community Health Care Organization Funabashi Central Hospital, Funabashi, Chiba 273-8556, Japan.
Shimada H; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2022 Aug 31; Vol. 24 (4), pp. 367. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
[S-methyl- C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapy.
Autorzy:
Narushima K; Department of Surgery, Secomedic Hospital, Chiba, Japan.; Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.; Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), QST Hospital, Chiba, Japan.
Nishii R; Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), Chiba, Japan. .
Okazumi S; Department of Surgery, Toho University Sakura Medical Center, Chiba, Japan.
Shimada H; Department of Gastroenterological Surgery, Toho University Graduate School of Medicine, Tokyo, Japan.
Akutsu Y; Miwa Central Clinic, Ibaraki, Japan.
Maeda T; Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), QST Hospital, Chiba, Japan.
Yasuda S; Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), QST Hospital, Chiba, Japan.; Department of Radiology, Chiba Rosai Hospital, Chiba, Japan.
Yamada S; Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), QST Hospital, Chiba, Japan.
Shuto K; Department of Surgery, Teikyo University Chiba Medical Center, Chiba, Japan.
Tamura K; Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
Yamazaki K; Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
Shinoto M; Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), QST Hospital, Chiba, Japan.
Ishikawa H; Quantum Life and Medical Science Directorate, National Institutes for Quantum Science and Technology (QST), QST Hospital, Chiba, Japan.
Mori M; Department of Surgery, Secomedic Hospital, Chiba, Japan.
Matsubara H; Department of Frontier Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Aug 11; Vol. 12 (1), pp. 13694. Date of Electronic Publication: 2022 Aug 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/radiotherapy
Heavy Ion Radiotherapy*/methods
Fluorodeoxyglucose F18 ; Humans ; Methionine ; Neoadjuvant Therapy ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography ; Radiopharmaceuticals
Czasopismo naukowe
Tytuł:
Comparison between a new assay system, Elecsys Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study.
Autorzy:
Suzuki T; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Oshima Y; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Shiratori F; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Nanami T; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Yajima S; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Sumazaki M; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Ushigome M; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Sugita H; Roche Diagnostics K.K., Tokyo 108-0075, Japan.
Eberl M; Department of Biostatistics and Advanced Data Analytics, Roche Diagnostics GmbH, Penzberg, D-82377 Bavaria, Germany.
Ogata H; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Hayashida T; Department of General and Gastroenterological Surgery, Keio University, Tokyo 160-8582, Japan.
Nakamura S; Division of Breast Surgical Oncology, Showa University, Tokyo 142-8666, Japan.
Nakagawa T; Division of Breast Surgery, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Shimada H; Department of Surgery, School of Medicine, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 142-8541, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2022 Jun 22; Vol. 17 (2), pp. 130. Date of Electronic Publication: 2022 Jun 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer.
Autorzy:
Ito M; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo 143-8541, Japan.
Oji Y; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Adachi M; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Imanishi R; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Alzaaqi S; Department of Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Hiwasa T; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo 143-8541, Japan.; Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Oshima Y; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Yajima S; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Suzuki T; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Nanami T; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Sumazaki M; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Shiratori F; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Funahashi K; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Sugiayama H; Department of Cancer Immunology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Shimada H; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo 143-8541, Japan.; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2022 Mar; Vol. 16 (3), pp. 74. Date of Electronic Publication: 2022 Feb 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers.
Autorzy:
Ito M; Department of Clinical Oncology, Toho University Graduate School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Hiwasa T; Department of Clinical Oncology, Toho University Graduate School of Medicine, Ota-ku, Tokyo 143-8541, Japan.; Department of Neurological Surgery, Chiba University Graduate School of Medicine, Chuo-ku, Chiba 260-8670, Japan.
Oshima Y; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Yajima S; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Suzuki T; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Nanami T; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Sumazaki M; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Shiratori F; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Funahashi K; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Takizawa H; Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chuo-ku, Chiba 260-0025, Japan.
Kashiwado K; Department of Neurology, Kashiwado Hospital, Chuo-ku, Chiba 260-0854, Japan.
Tochigi N; Department of Surgical Pathology, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Shimada H; Department of Clinical Oncology, Toho University Graduate School of Medicine, Ota-ku, Tokyo 143-8541, Japan.; Department of Gastroenterological Surgery, Toho University School of Medicine, Ota-ku, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2021 Nov; Vol. 15 (5), pp. 237. Date of Electronic Publication: 2021 Sep 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker.
Autorzy:
Nanami T; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Hoshino I; Division of Gastroenterological Surgery, Chiba Cancer Center, Chiba 260-8717, Japan.
Shiratori F; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Yajima S; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Oshima Y; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Suzuki T; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Ito M; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Hiwasa T; Department of Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan.
Kuwajima A; Medical and Biological Laboratories Co., Ltd., Nagoya, Aichi 460-0008, Japan.
Shimada H; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.; Division of Gastroenterological Surgery, Chiba Cancer Center, Chiba 260-8717, Japan.; Department of Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan.; Department of Gastroenterological Surgery, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2021 Sep; Vol. 15 (3), pp. 179. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
Autorzy:
Li SY; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.
Yoshida Y; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Kobayashi E; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Kubota M; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.
Matsutani T; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.
Mine S; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.; Department of Neurological Surgery, Chiba Prefectural Sawara Hospital, Chiba, 287-0003, Japan.; Department of Neurological Surgery, Chiba Cerebral and Cardiovascular Center, Chiba, 290-0512, Japan.
Machida T; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.; Department of Neurological Surgery, Chiba Cerebral and Cardiovascular Center, Chiba, 290-0512, Japan.; Department of Neurosurgery, Eastern Chiba Medical Center, Chiba, 283-8686, Japan.
Maezawa Y; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Takemoto M; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, Chiba, 286-8686, Japan.
Yokote K; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Kobayashi Y; Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Takizawa H; Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chiba, 260-0025, Japan.
Sata M; Department of Public Health Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, 305-8575, Japan.; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Yamagishi K; Department of Public Health Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, 305-8575, Japan.
Iso H; Department of Public Health, Social Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
Sawada N; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, 104-0045, Japan.
Tsugane S; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, 104-0045, Japan.
Kobayashi S; Department of Laboratory Medicine and Division of Clinical Genetics, Chiba University Hospital, Chiba, 260-8677, Japan.; Department of Medical Technology and Sciences, School of Health Sciences at Narita, International University of Health and Welfare, Chiba, 286-8686, Japan.
Matsushita K; Department of Laboratory Medicine and Division of Clinical Genetics, Chiba University Hospital, Chiba, 260-8677, Japan.
Nomura F; Division of Clinical Genetics, Chiba Foundation for Health Promotion & Disease Prevention, Chiba, 261-0002, Japan.
Matsubara H; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Sumazaki M; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Ito M; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Yajima S; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Shimada H; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Iwase K; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Ashino H; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Wang H; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Anesthesia, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, Guangdong, People's Republic of China.
Goto K; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Tomiyoshi G; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Shinmen N; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Nakamura R; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Kuroda H; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Iwadate Y; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Hiwasa T; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba, 260-8670, Japan. hiwasa_.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan. hiwasa_.; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan. hiwasa_.; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan. hiwasa_.; Department of Anesthesia, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, Guangdong, People's Republic of China. hiwasa_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jun 29; Vol. 11 (1), pp. 13450. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Adaptor Protein Complex 3*/blood
Adaptor Protein Complex 3*/immunology
Adaptor Protein Complex delta Subunits*/blood
Adaptor Protein Complex delta Subunits*/immunology
Atherosclerosis*/blood
Atherosclerosis*/complications
Atherosclerosis*/immunology
Autoantibodies*/blood
Autoantibodies*/immunology
Immunoglobulin G*/blood
Immunoglobulin G*/immunology
Ischemic Stroke*/blood
Ischemic Stroke*/etiology
Ischemic Stroke*/immunology
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Risk Factors
Czasopismo naukowe
Tytuł:
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
Autorzy:
Hiwasa T; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan. hiwasa_.; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan. hiwasa_.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan. hiwasa_.
Wang H; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Anesthesia, The First Affiliated Hospital, Jinan University, Guanzhou, 510632, P. R. China.
Goto KI; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Mine S; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Neurological Surgery, Chiba Prefectural Sawara Hospital, Chiba, 287-0003, Japan.; Department of Neurological Surgery, Chiba Cerebral and Cardiovascular Center, Chiba, 290-0512, Japan.
Machida T; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Neurological Surgery, Chiba Cerebral and Cardiovascular Center, Chiba, 290-0512, Japan.; Department of Neurosurgery, Eastern Chiba Medical Center, Chiba, 283-8686, Japan.
Kobayashi E; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Yoshida Y; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Adachi A; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Matsutani T; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Sata M; Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba, Tsukuba, 305-8575, Japan.; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Yamagishi K; Department of Public Health Medicine, Faculty of Medicine, and Health Services Research and Development Center, University of Tsukuba, Tsukuba, 305-8575, Japan.
Iso H; Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, 565-0871, Japan.
Sawada N; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, 104-0045, Japan.
Tsugane S; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, 104-0045, Japan.
Kunimatsu M; Department of Home Economics, Nagoya Women's University, Nagoya, 467-8610, Japan.
Kamitsukasa I; Department of Neurology, Chiba Rosai Hospital, Chiba, 290-0003, Japan.; Department of Neurology, Chibaken Saiseikai Narashino Hospital, Chiba, 275-8580, Japan.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Sugimoto K; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Uzawa A; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Muto M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Kuwabara S; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Kobayashi Y; Department of Cardiovascular Medicine, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Ohno M; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.; Department of Pharmacology, Shiga University of Medical Science, Shiga, 520-2192, Japan.
Nishi E; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.; Department of Pharmacology, Shiga University of Medical Science, Shiga, 520-2192, Japan.
Hattori A; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Yamamoto M; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Maezawa Y; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Kobayashi K; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Ishibashi R; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Takemoto M; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, Chiba, 286-8686, Japan.
Yokote K; Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Takizawa H; Port Square Kashiwado Clinic, Kashiwado Memorial Foundation, Chiba, 260-0025, Japan.
Kishimoto T; Department of Molecular Pathology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Matsushita K; Department of Laboratory Medicine & Division of Clinical Genetics, Chiba University Hospital, Chiba, 260-8677, Japan.
Kobayashi S; Department of Laboratory Medicine & Division of Clinical Genetics, Chiba University Hospital, Chiba, 260-8677, Japan.; Department of Medical Technology and Sciences, School of Health Sciences at Narita, International University of Health and Welfare, Chiba, 286-8686, Japan.
Nomura F; Division of Clinical Genetics, Chiba Foundation for Health Promotion and Disease Prevention, Chiba, 261-0002, Japan.
Arasawa T; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Kagaya A; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Maruyama T; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Matsubara H; Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Tomiita M; Department of Allergy and Rheumatology, Chiba Children's Hospital, Chiba, 266-0007, Japan.
Hamanaka S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Imai Y; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Nakagawa T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Terada J; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Matsumura T; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Katsumata Y; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Naito A; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Tanabe N; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Sakao S; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Tatsumi K; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Ito M; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Shiratori F; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Sumazaki M; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Yajima S; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Shimada H; Department of Gastroenterological Surgery and Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan.
Shirouzu M; Division of Structural and Synthetic Biology, RIKEN Center for Life Science Technologies, Yokohama, Kanagawa, 230-0045, Japan.
Yokoyama S; RIKEN Structural Biology Laboratory, Yokohama, Kanagawa, 230-0045, Japan.
Kudo T; Celish FD Inc., Chiba, Japan.
Doi H; Celish FD Inc., Chiba, Japan.
Iwase K; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Ashino H; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Li SY; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Kubota M; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.
Tomiyoshi G; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Shinmen N; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Nakamura R; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Kuroda H; Medical Project Division, Research Development Center, Fujikura Kasei Co., Saitama, 340-0203, Japan.
Iwadate Y; Department of Neurological Surgery, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan.; Comprehensive Stroke Center, Chiba University Hospital, Chiba, 260-8677, Japan.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2021 Jun 09; Vol. 19 (1), pp. 131. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies*/blood
Brain Ischemia*/diagnosis
Ischemic Stroke*
Stroke*/diagnosis
Case-Control Studies ; Cleavage And Polyadenylation Specificity Factor/immunology ; DNA-Binding Proteins/immunology ; Forkhead Transcription Factors/immunology ; Humans
Czasopismo naukowe
Tytuł:
Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer.
Autorzy:
Ushigome M; Department of Surgery, School of Medicine, Toho University, Ota-ku, Tokyo 143-8541, Japan.
Shimada H; Department of Surgery, School of Medicine, Toho University, Ota-ku, Tokyo 143-8541, Japan.
Nabeya Y; Division of Gastroenterological Surgery, Chiba Cancer Center, Chuo-ku, Chiba 260-8717, Japan.
Shiratori F; Department of Surgery, School of Medicine, Toho University, Ota-ku, Tokyo 143-8541, Japan.; Division of Gastroenterological Surgery, Chiba Cancer Center, Chuo-ku, Chiba 260-8717, Japan.
Soda H; Division of Gastroenterological Surgery, Chiba Cancer Center, Chuo-ku, Chiba 260-8717, Japan.
Takiguchi N; Division of Gastroenterological Surgery, Chiba Cancer Center, Chuo-ku, Chiba 260-8717, Japan.
Hoshino I; Division of Gastroenterological Surgery, Chiba Cancer Center, Chuo-ku, Chiba 260-8717, Japan.
Kuwajima A; Medical and Biological Laboratories Co., Ltd, Naka-ku, Nagoya 460-0008, Japan.
Kaneko T; Department of Surgery, School of Medicine, Toho University, Ota-ku, Tokyo 143-8541, Japan.
Funahashi K; Department of Surgery, School of Medicine, Toho University, Ota-ku, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2021 Jan; Vol. 14 (1), pp. 18. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
Autorzy:
Hoshino I; Division of Gastroenterological Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba, 260-8717, Japan. .
Nabeya Y; Division of Gastroenterological Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba, 260-8717, Japan.
Takiguchi N; Division of Gastroenterological Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba, 260-8717, Japan.
Gunji H; Division of Gastroenterological Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba, 260-8717, Japan.
Ishige F; Department of Hepatobiliary and Pancreatic Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba, Japan.
Iwatate Y; Department of Hepatobiliary and Pancreatic Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba, Japan.
Kuwajima A; Medical & Biological Laboratories Co., Ltd, 4-5-3 Sakae, Naka-ku, Nagoya, 460-0008, Japan.
Shiratori F; Division of Gastroenterological Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba, 260-8717, Japan.; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-ku, Tokyo, 143-8541, Japan.
Okada R; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-ku, Tokyo, 143-8541, Japan.
Shimada H; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-ku, Tokyo, 143-8541, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Oct 17; Vol. 20 (1), pp. 1007. Date of Electronic Publication: 2020 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens, Neoplasm/*genetics
Autoantibodies/*blood
Esophageal Neoplasms/*immunology
Esophageal Squamous Cell Carcinoma/*immunology
Aged ; Aged, 80 and over ; Antigens, Neoplasm/immunology ; Esophageal Neoplasms/genetics ; Esophageal Squamous Cell Carcinoma/genetics ; Female ; Galectin 1/genetics ; Galectin 1/immunology ; Gene Expression Regulation, Neoplastic ; HSP70 Heat-Shock Proteins/genetics ; HSP70 Heat-Shock Proteins/immunology ; Humans ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Tytuł:
Prevalence of autoantibodies against Ras-like GTPases, RalA, in patients with gastric cancer.
Autorzy:
Nanami T; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Hoshino I; Division of Gastroenterological Surgery, Chiba Cancer Center, Chiba 260-8717, Japan.
Ito M; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Yajima S; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Oshima Y; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Suzuki T; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Shiratori F; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Nabeya Y; Division of Gastroenterological Surgery, Chiba Cancer Center, Chiba 260-8717, Japan.
Funahashi K; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.
Shimada H; Department of Surgery, School of Medicine, Toho University, Tokyo 143-8541, Japan.; Department of Gastroenterological Surgery and Clinical Oncology, Graduate School of Medicine, Toho University, Tokyo 143-8541, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2020 Oct; Vol. 13 (4), pp. 28. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients.
Autorzy:
Sumazaki M; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, Japan.; Department of Surgery, Division of Breast and Endocrine Surgery, Toho University Medical Center, Omori Hospital, Tokyo, Japan.
Kaneko K; Department of Internal Medicine (Omori), Division of Rheumatology, Toho University School of Medicine, Tokyo, Japan.
Ito M; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, Japan.
Oshima Y; Department of Surgery, Division of Gastroenterological Surgery, Toho University Medical Center, Omori Hospital, Tokyo, Japan.
Saito F; Department of Surgery, Division of Breast and Endocrine Surgery, Toho University Medical Center, Omori Hospital, Tokyo, Japan.
Ogata H; Department of Surgery, Division of Breast and Endocrine Surgery, Toho University Medical Center, Omori Hospital, Tokyo, Japan.
Shibuya K; Department of Surgical Pathology, Toho University Medical Center, Omori Hospital, Tokyo, Japan.
Shimada H; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, Japan.; Department of Surgery, Division of Gastroenterological Surgery, Toho University Medical Center, Omori Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2020 Apr 21; Vol. 21, pp. e922004. Date of Electronic Publication: 2020 Apr 21.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Dermatomyositis/*diagnosis
Esophageal Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Autoantibodies/blood ; Early Detection of Cancer ; Esophageal Neoplasms/surgery ; Fatal Outcome ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Transcription Factors/immunology
Czasopismo naukowe
Tytuł:
High serum PD-L1 level is a poor prognostic biomarker in surgically treated esophageal cancer.
Autorzy:
Ito M; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, Japan.
Yajima S; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Suzuki T; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Oshima Y; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Nanami T; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Sumazaki M; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Shiratori F; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Funahashi K; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Tochigi N; Department of Surgical Pathology, Toho University School of Medicine, Tokyo, Japan.
Shimada H; Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, Japan.; Department of Gastroenterological Surgery, Toho University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Feb; Vol. 9 (4), pp. 1321-1327. Date of Electronic Publication: 2019 Dec 21.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Esophagectomy*
B7-H1 Antigen/*blood
Biomarkers, Tumor/*blood
Esophageal Neoplasms/*mortality
Aged ; Esophageal Neoplasms/blood ; Esophageal Neoplasms/diagnosis ; Esophageal Neoplasms/therapy ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Staging ; Preoperative Period ; Prognosis ; Reference Values ; Risk Assessment/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.
Autorzy:
Moll S; Department of Pathology, University Hospital of Geneva, Geneva, Switzerland.
Yasui Y; Research Division, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.
Abed A; INSERM, UMR S 1155, Hôpital Tenon, 75020, Paris, France.
Murata T; Research Division, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.
Shimada H; Research Division, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.; Chugai Pharmabody Research Pte. Ltd., Singapore, Singapore.
Maeda A; Research Division, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.
Fukushima N; Research Division, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.
Kanamori M; Research Division, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.; Chugai Pharmabody Research Pte. Ltd., Singapore, Singapore.
Uhles S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Badi L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Cagarelli T; Department of Pathology, University Hospital of Geneva, Geneva, Switzerland.
Formentini I; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Late Stage, AstraZeneca, Göteborgs, Sweden.
Drawnel F; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Georges G; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Munich, Germany.
Bergauer T; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Gasser R; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Bonfil RD; Department of Pathology, College of Medical Sciences, Nova Southeastern University, Fort Lauderdale, FL, USA.
Fridman R; Department of Pathology, Wayne State University, Detroit, MI, USA.
Richter H; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Funk J; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Moeller MJ; Department of Nephrology and Clinical Immunology, RWTH University, Aachen, Germany.
Chatziantoniou C; INSERM, UMR S 1155, Hôpital Tenon, 75020, Paris, France.
Prunotto M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. .; Office of Innovation, Immunology, Infectious Diseases & Ophthalmology (I2O), Roche and Genentech Late Stage Development, 124 Grenzacherstrasse, 4070, Basel, Switzerland. .; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2018 Jun 01; Vol. 16 (1), pp. 148. Date of Electronic Publication: 2018 Jun 01.
Typ publikacji:
Journal Article
MeSH Terms:
Discoidin Domain Receptor 1/*antagonists & inhibitors
Glomerulonephritis/*drug therapy
Glomerulonephritis/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Animals ; Discoidin Domain Receptor 1/metabolism ; Disease Models, Animal ; Epithelial Cells/metabolism ; Epithelial Cells/pathology ; Epithelium/pathology ; Female ; Gene Expression Profiling ; Gene Expression Regulation ; Gene Regulatory Networks ; Glomerulonephritis/genetics ; Glomerulonephritis/pathology ; Humans ; Inflammation/pathology ; Kidney/pathology ; Male ; Mice ; Middle Aged ; Phenotype
Czasopismo naukowe
Tytuł:
Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes.
Autorzy:
Yamauchi S; Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.; Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Zhong B; Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.; Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kawamura K; Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
Yang S; Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.; Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kubo S; Department of Genetics, Hyogo College of Medicine, Nishinomiya, Japan.
Shingyoji M; Division of Respirology, Chiba Cancer Center, Chiba, Japan.
Sekine I; Department of Medical Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Tada Y; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tatsumi K; Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Shimada H; Department of Surgery, School of Medicine, Toho University, Tokyo, Japan.
Hiroshima K; Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan.
Tagawa M; Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan. .; Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2017 Sep 05; Vol. 17 (1), pp. 622. Date of Electronic Publication: 2017 Sep 05.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression*
Regulatory Sequences, Nucleic Acid*
Virus Replication*
Adenoviridae/*genetics
Adenoviridae/*metabolism
Adenovirus E1A Proteins/*metabolism
Genetic Vectors/*genetics
Tumor Suppressor Protein p53/*genetics
Cell Line, Tumor ; Cytopathogenic Effect, Viral ; Genes, Reporter ; Genotype ; Humans ; Protein Binding ; Receptors, Virus/genetics ; Receptors, Virus/metabolism ; Transcriptional Activation ; Transduction, Genetic ; Transgenes ; Tumor Suppressor Protein p53/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies